- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3595EUR$3,750USD£3,004GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1198EUR$1,250USD£1,001GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1438EUR$1,500USD£1,202GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1438EUR$1,500USD£1,202GBP
- Drug Pipelines
- April 2024
- 40 Pages
Global
From €1198EUR$1,250USD£1,001GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1438EUR$1,500USD£1,202GBP
- Report
- October 2023
- 190 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- May 2022
- 125 Pages
Global
From €2397EUR$2,500USD£2,003GBP
Noradrenaline is a drug used in the treatment of cardiovascular diseases. It is a catecholamine, a type of neurotransmitter, and is used to treat low blood pressure, heart failure, and shock. It works by stimulating the sympathetic nervous system, which increases heart rate and blood pressure. It is also used to treat arrhythmias, or irregular heartbeats. Noradrenaline is usually administered intravenously, and is often used in combination with other drugs.
Noradrenaline is a widely used drug in the cardiovascular market, and is often used in combination with other drugs to treat a variety of conditions. It is generally considered to be safe and effective, and is available in both generic and branded forms.
Some companies in the Noradrenaline market include Pfizer, Novartis, Merck, and Sanofi. Show Less Read more